USC Survey: Paying $51 or More a Month Predicted Stopping a GLP-1 More Strongly Than Vomiting Did
Presenting at ObesityWeek, USC's Alison Sexton Ward reported that 1,256 of 9,139 Understanding America Study respondents had ever used a GLP-1, and 43% of those taking it only for weight loss had no insurance coverage for it, Medscape reported. Out-of-pocket costs of $51 or more a month raised the hazard of stopping 2.7-fold compared with no copay, versus 2.1-fold for vomiting, while having diabetes halved it. Discontinuation reached 22.1% at 12 months and 33.4% at 24 months.